Business ❯ Manufacturing

Pharmaceuticals

IV Fluid Production Eli Lilly Microcrystalline Cellulose Pharmaceutical Excipients Tariff Impact Foreign Products IV Solutions Chemical Manufacturing Supply Chain Management Alcon Laboratories Sterile Injectable Medicines Tariff Implications Investments Nutraceuticals Vitamin-A Palmitate Chemical Production Safety Protocols Contraceptives Production Facilities Export Strategies Tariff Policy Tariffs Export Statistics Regulated Products Truck Manufacturing Packaging Boots Gel Pharmaceutical Company Industrial Accidents Cold Chain Management Investment Drug Production Supply Chain Supply Chain Issues IV Solutions Production Medical Supplies Baxter International IV Production Drug Manufacturing Contract Manufacturing

Eli Lilly Picks Huntsville for $6 Billion API Plant to Supply Next-Gen Drugs

The move advances onshoring of active ingredients to support orforglipron within Lilly’s $27 billion U.S. buildout.